Events - Info Day, Horizon 2020 'Health, demographic change and wellbeing' - 12 July 2018, Brussels, Belgium

Health and life sciences - Thu, 06/14/2018 - 02:00

Save the date! The European Commission is organising an Information Day to present the 2019 funding opportunities of the Health, demographic change and wellbeing societal challenge.

This half-day event (9:00-12:00) will only be webstreamed. The link will be published on this page a week before the event.

The programme will be online in the coming days.

Please send your questions preferably in advance at this address: RTD-HEALTH-INFODAY@ec.europa.eu.

Questions - which can also be sent to this address during the webinar - should concern the WP 2019 topics of Horizon 2020 Societal Challenge 1 (Health, Demographic Change and Wellbeing).

They may be related to the text of specific topics or to other questions of practical relevance for applicants to these SC1 2019 call topics. We ask for your understanding that we will at this event not respond to questions on 2020 call topics, on issues outside the scope of H2020 SC1 or on Horizon Europe.

Connected to the Open Info Day, the EU-funded projects Health-NCP-Net 2.0 is organizing a free of charge Brokerage Event on Sept. 3-4 2018 in Oslo which is meant to assist you in finding the right project partners for the upcoming 2019 Health calls.

Categories: European Commission

Research Headlines - A meditative approach to active and healthy ageing

Health and life sciences - Wed, 06/13/2018 - 02:00
EU-funded research is exploring how meditation training and other preventive programmes can help Europe's ageing society stay mentally active and physically healthy for longer. The findings can help shape a variety of programmes and policies.
Categories: European Commission

Research Headlines - Protecting unborn babies from Zika

Health and life sciences - Wed, 06/13/2018 - 02:00
A loan supported by the InnovFin-EU finance for innovators initiative under the EU's Horizon 2020 programme and extended by the European Investment Bank is helping France-based biotech company Valneva develop a Zika vaccine that is safe during pregnancy. This could protect unborn babies from birth defects linked to the mosquito-borne virus.
Categories: European Commission

Research Headlines - Pooling resources to make better diagnoses of rare diseases

Health and life sciences - Tue, 06/12/2018 - 02:00
By pooling patient data and applying state-of-the art genetic methods, EU-funded research is improving the diagnosis of rare diseases that affect the lives of tens of millions of EU citizens.
Categories: European Commission

Research Headlines - Fertile research on the causes of pre-eclampsia

Health and life sciences - Mon, 06/11/2018 - 02:00
Pre-eclampsia is a potentially life-threatening condition that can develop in pregnant women. A number of factors are known to increase the risk, but the actual causes of this hypertensive disorder remain unclear. Researchers in Kazakhstan were involved in an EU-funded project that discovered an exciting lead: the baby’s genes also appear to play a role.
Categories: European Commission

Research Headlines - A faster way to spot the tell-tale signs of cancer-causing drugs

Health and life sciences - Fri, 06/08/2018 - 02:00
An EU- and industry-funded project has identified potential biomarkers that could indicate how likely a drug is to cause cancer at an earlier stage of testing than is currently possible, which could save drug companies time and money - and lead to safer drugs reaching patients faster.
Categories: European Commission

Research Headlines - Mapping climate change impacts on tropical diseases

Health and life sciences - Thu, 06/07/2018 - 02:00
An atlas developed by an EU-funded project maps the risk in eastern Africa of three tropical diseases. Now used in teaching and research, it could one day support models that better predict how environmental changes might impact public health.
Categories: European Commission

Events - IMI: Celebrating 10 Years of Medical Innovations - 27 June 2018, Brussels, Belgium

Health and life sciences - Wed, 06/06/2018 - 02:00

Organised jointly by the Innovative Medicines Initiative together with the European Commission and the European Federation of Pharmaceutical Industries and Associations, the event will take place at the European Commission’s Charlemagne Building in Brussels, Belgium on Wednesday 27 June 2018.

The goal of this celebration is to highlight the successes of IMI projects, showcasing tangible results that are translated into concrete benefits for European citizens. Deadline for registrations: 19 June

Categories: European Commission

Research Headlines - Fever pitch: improving the management of febrile patients

Health and life sciences - Wed, 06/06/2018 - 02:00
EU-funded researchers are seeking to improve the diagnosis and management of patients with fever through the identification of new biomarkers that can differentiate between bacterial and viral infection. Once found, the biomarkers will be evaluated across different European healthcare models.
Categories: European Commission

Research Headlines - How best to help people stop smoking?

Health and life sciences - Tue, 06/05/2018 - 02:00
The dangers of smoking are widely recognised, but what interventions work best to help people quit this deadly habit? EU-funded researchers are assessing a range of existing approaches and new cessation treatments. The results will inform public health policy in Europe and the wider world.
Categories: European Commission

Research Headlines - Tackling depression with digital tools

Health and life sciences - Mon, 06/04/2018 - 02:00
Internet-based services can treat people with depression, improve access to therapy and raise the quality of care, according to an EU-funded project that has conducted the first large-scale trials of a novel blended treatment approach using standard therapy sessions combined with digital tools.
Categories: European Commission

Research Headlines - New hope for children with thalassaemia

Health and life sciences - Fri, 06/01/2018 - 02:00
An international group of EU-funded researchers has investigated the safety and efficacy of using the drug deferiprone to treat children with the blood disorder beta-thalassaemia major. The news is good.
Categories: European Commission

Research Headlines - Leading the fight against antimicrobial resistance

Health and life sciences - Tue, 05/29/2018 - 02:00
EU-funded researchers have shown how nanoparticles can deliver drugs directly to the site of an infection. This preclinical research promises more effective treatments and the prospect of bypassing the threat of antimicrobial resistance.
Categories: European Commission

Research Headlines - Conscious awareness... Think about it!

Health and life sciences - Mon, 05/28/2018 - 02:00
What is conscious awareness? An EU-funded study went looking for answers to this eternal question using advanced technology. The findings provide insight into what motivates or interests people, and the perception process behind powerful neurological drivers of human behaviour.
Categories: European Commission

Research Headlines - Understanding the power of art on the brain

Health and life sciences - Mon, 05/28/2018 - 02:00
The power of a painting to trigger myriad emotional and cognitive responses has been recognised throughout history. But how and why art has such a profound effect on our brains is a mystery that is only now starting to be unravelled, thanks to EU-funded research.
Categories: European Commission

Research Headlines - E-health solutions to support cancer rehabilitation

Health and life sciences - Fri, 05/25/2018 - 02:00
Active rehabilitation has emerged as a powerful tool in cancer care. However, its full potential to help restore survivors' functional capacity, boost their quality of life and possibly even reduce the risk of recurrence has yet to be tapped. EU-funded researchers are looking into e-health solutions to take the technique another step further.
Categories: European Commission

Events - ICPerMed Conference 2018 'Personalised Medicine in Action' - 20-21 November 2018, Berlin, Germany

Health and life sciences - Thu, 05/24/2018 - 02:00

The first ICPerMed Conference 'Personalised Medicine in Action' will take place on 20-21 November 2018 at the dbb forum in Berlin, Germany.

The main focus of this conference is to present best practice examples of successful implementation of personalised medicine approaches. This is complemented by high-level keynote talks addressing different aspects of personalised medicine.

The conference will start in the morning of November 20 at 9:00 AM and will finish on November 21 at 2:00 PM.

Categories: European Commission

Research Headlines - A more efficient way of designing proteins

Health and life sciences - Wed, 05/16/2018 - 02:00
Thanks to the algorithms that are being developed by an EU-funded project, scientists have an easier time finding the information they need to more efficiently design new proteins that can be used, for example, in the development of new medicines.
Categories: European Commission

Research Headlines - New light on sub-Saharan nutrition research

Health and life sciences - Tue, 05/08/2018 - 02:00
Many countries in sub-Saharan Africa still suffer from high rates of malnutrition, despite international efforts to address the issue. An EU-funded project brought together African researchers and stakeholder organisations to define research priorities that could improve results and strengthen the continent's capacity in this field.
Categories: European Commission

Research Headlines - Assistive technology offers a helping hand

Health and life sciences - Fri, 05/04/2018 - 02:00
An EU co-funded research network is working on pioneering assistive technologies which can support independent living and enable choice among those diagnosed with intellectual disabilities and/or autism, in a bid to improve their quality of life.
Categories: European Commission

Pages

Subscribe to Health-NCP-Net aggregator